Search Header Logo
Tiziana Life Sciences Chairman on Alzheimer and Covid Efforts

Tiziana Life Sciences Chairman on Alzheimer and Covid Efforts

Assessment

Interactive Video

Business, Health Sciences, Biology

University

Practice Problem

Hard

Created by

Wayground Content

FREE Resource

The video discusses the resurgence of COVID-19 due to the Delta variant and explores a nasal spray treatment developed by Tiziana that targets the immune system. This treatment has potential applications for Alzheimer's, as it addresses inflammation, a common factor in various diseases. The video also highlights the broad applicability of this treatment for conditions like MS, ALS, and Crohn's disease.

Read more

7 questions

Show all answers

1.

OPEN ENDED QUESTION

3 mins • 1 pt

What is the significance of the Delta variant in relation to COVID-19 infections?

Evaluate responses using AI:

OFF

2.

OPEN ENDED QUESTION

3 mins • 1 pt

What are the two stages of the coronavirus infection as described in the text?

Evaluate responses using AI:

OFF

3.

OPEN ENDED QUESTION

3 mins • 1 pt

How does the nasal spray being developed aim to modulate the immune system?

Evaluate responses using AI:

OFF

4.

OPEN ENDED QUESTION

3 mins • 1 pt

What role does inflammation play in both COVID-19 and Alzheimer's disease according to the text?

Evaluate responses using AI:

OFF

5.

OPEN ENDED QUESTION

3 mins • 1 pt

In what ways could the treatment being developed for Alzheimer's be considered a breakthrough?

Evaluate responses using AI:

OFF

6.

OPEN ENDED QUESTION

3 mins • 1 pt

What constitutes success in treating Alzheimer's disease as discussed in the text?

Evaluate responses using AI:

OFF

7.

OPEN ENDED QUESTION

3 mins • 1 pt

What potential applications does the nasal spray have beyond treating COVID-19?

Evaluate responses using AI:

OFF

Access all questions and much more by creating a free account

Create resources

Host any resource

Get auto-graded reports

Google

Continue with Google

Email

Continue with Email

Classlink

Continue with Classlink

Clever

Continue with Clever

or continue with

Microsoft

Microsoft

Apple

Apple

Others

Others

Already have an account?